Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ephedrine + phenylephrine is a combination of two sympathomimetic agents used primarily to prevent and treat hypotension during spinal anesthesia, particularly in cesarean sections. The combination leverages complementary mechanisms: ephedrine acts as both a direct and indirect sympathomimetic with mixed α and β effects, while phenylephrine is predominantly an α-adrenergic agonist. This combination allows for lower doses of each individual drug, potentially reducing side effects while maintaining efficacy. The physiologic rationale for combining these agents is to increase the α/β-agonist activity ratio, where ephedrine's positive chronotropic and inotropic effects may counter the reflex decreases in heart rate and cardiac output that phenylephrine can induce.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on ephedrine + phenylephrine.